Translation initiation in the hepatitis C virus (HCV) occurs through a cap-independent mechanism that involves an internal ribosome entry site (IRES) capable of interacting with and utilizing the eukaryotic translational machinery. In this review, we focus on the structural configuration of the different HCV IRES domains and the impact of IRES primary sequence variations on secondary structure conservation and function. In some cases, multiple mutations, even those scattered across different domains, led to restoration of the translational activity of the HCV IRES, although the individual occurrences of these mutations were found to be deleterious. We propose that such observation may be attributed to probable long-range inter- and/or intra-domain functional interactions. The precise functioning of the HCV IRES requires the specific interaction of its domains with ribosomal subunits and a subset of eukaryotic translation initiation factors (eIFs). The structural conformation, sequence preservation and variability, and translational machinery association with the HCV IRES regions are also thoroughly discussed, along with other factors that can affect and influence the formation of translation initiation complexes.

Department of Genetics and Microbiology Faculty of Science Charles University Prague Prague 2 Czech Republic

Zobrazit více v PubMed

Gravitz L. A smouldering public-health crisis. Nature. 2011;474:S2–S4. PubMed

Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436:967–972. PubMed

Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130:231–264. PubMed

Sofia MJ, Bao D, Chang W, Du JF, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang PY, Zhang HR. Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem. 2010;53:7202–7218. et al. PubMed

Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR. Sofosbuvir for previously untreated chronic hepatitis C infection. New Engl J Med. 2013;368:1878–1887. et al. PubMed

Fried MW, Buti M, Dore GJ, Flisiak R, Ferenci P, Jacobson I, Marcellin P, Manns M, Nikitin I, Poordad F. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: the randomized PILLAR study. Hepatology. 2013;58:1918–1929. et al. PubMed PMC

Malcolm BA, Arassappan A, Bennett F, Bogen S, Chase R, Chen K, Chen T, Ingravallo P, Jao E, Kong S. SCH 503034, a mechanism-based inhibitor of hepatitis C virus (HCV) NS3 protease suppresses polyprotein maturation and enhances the antiviral activity of interferona-211 (INF) Hepatology. 2005;42:535a–536a. et al. PubMed PMC

Perni RB, Almquist SJ, Byrn RA, Chandorkar G, Chaturvedi PR, Courtney LF, Decker CJ, Dinehart K, Gates CA, Harbeson SL. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease. Antimicrob Agents Chemother. 2006;50:899–909. et al. PubMed PMC

Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 1991;88:2451–2455. et al. PubMed PMC

Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105–1113. PubMed PMC

Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA. 1996;2:955–968. PubMed PMC

Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 1998;12:67–83. PubMed PMC

Ji H, Fraser CS, Yu YH, Leary J, Doudna JA. Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA. Proc Natl Acad Sci USA. 2004;101:16990–16995. PubMed PMC

Locker N, Easton LE, Lukavsky PJ. HCV and CSFVIRES domain II mediate eIF2 release during 80S ribosome assembly. Embo J. 2007;26:795–805. PubMed PMC

Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol. 1993;67:3338–3344. PubMed PMC

Tsukiyamakohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis-C virus-Rna. J Virol. 1992;66:1476–1483. PubMed PMC

Brown EA, Zhang HC, Ping LH, Lemon SM. Secondary structure of the 5′ nontranslated regions of hepatitis-C virus and pestivirus genomic Rnas. Nucleic Acids Res. 1992;20:5041–5045. PubMed PMC

Zhao WD, Wimmer E. Genetic analysis of a poliovirus/hepatitis C virus chimera: new structure for domain II of the internal ribosomal entry site of hepatitis C virus. J Virol. 2001;75:3719–3730. PubMed PMC

Lukavsky PJ, Kim I, Otto GA, Puglisi JD. Structure of HCVIRES domain II determined by NMR. Nat Struct Biol. 2003;10:1033–1038. PubMed

Kieft JS, Zhou KH, Grech A, Jubin R, Doudna JA. Crystal structure of an RNA tertiary domain essential to HCVIRES-mediated translation initiation. Nat Struct Biol. 2002;9:370–374. PubMed

Lukavsky PJ, Otto GA, Lancaster AM, Sarnow P, Puglisi JD. Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. Nat Struct Biol. 2000;7:1105–1110. PubMed

Collier AJ, Gallego J, Klinck R, Cole PT, Harris SJ, Harrison GP, Aboul-ela F, Varani G, Walker S. A conserved RNA structure within the HCVIRES eIF3-binding site. Nat Struct Biol. 2002;9:375–380. PubMed

Rijnbrand R, Thiviyanathan V, Kaluarachchi K, Lemon SM, Gorenstein DG. Mutational and structural analysis of stem-loop IIIc of the hepatitis C virus and GB virus B internal ribosome entry sites. J Mol Biol. 2004;343:805–817. PubMed

Berry KE, Waghray S, Mortimer SA, Bai Y, Doudna JA. Crystal structure of the HCV IRES central domain reveals strategy for start-codon positioning. Structure. 2011;19:1456–1466. PubMed PMC

Kieft JS, Zhou KH, Jubin R, Murray MG, Lau JYN, Doudna JA. The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J Mol Biol. 1999;292:513–529. PubMed

Spahn CMT, Kieft JS, Grassucci RA, Penczek PA, Zhou KH, Doudna JA, Frank J. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit. Science. 2001;291:1959–1962. PubMed

Odreman-Macchioli F, Baralle FE, Buratti E. Mutational analysis of the different bulge regions of hepatitis C virus domain II and their influence on internal ribosome entry site translational ability. J Biol Chem. 2001;276:41648–41655. PubMed

Kalliampakou KI, Psaridi-Linardaki L, Mavromara P. Mutational analysis of the apical region of domain II of the HCVIRES. Febs Lett. 2002;511:79–84. PubMed

Kolupaeva VG, Pestova TV, Hellen CUT. An enzymatic footprinting analysis of the interaction of 40S ribosomal subunits with the internal ribosomal entry site of hepatitis C virus. J Virol. 2000;74:6242–6250. PubMed PMC

Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CU. Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol. 1998;72:4775–4782. PubMed PMC

Rijnbrand R, Bredenbeek P, Vanderstraaten T, Whetter L, Inchauspe G, Lemon S, Spaan W. Almost the Entire 5′ Non-Translated Region of Hepatitis-C Virus Is Required for Cap-Independent Translation. Febs Lett. 1995;365:115–119. PubMed

Honda M, Ping LH, Rijnbrand RCA, Amphlett E, Clarke B, Rowlands D, Lemon SM. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology. 1996;222:31–42. PubMed

Lytle JR, Wu L, Robertson HD. The ribosome binding site of hepatitis C virus mRNA. J Virol. 2001;75:7629–7636. PubMed PMC

Lytle JR, Wu L, Robertson HD. Domains on the hepatitis C virus internal ribosome entry site for 40s subunit binding. RNA. 2002;8:1045–1055. PubMed PMC

Berry KE, Waghray S, Doudna JA. The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit. RNA. 2010;16:1559–1569. PubMed PMC

Kieft JS, Zhou KH, Jubin R, Doudna JA. Mechanism of ribosome recruitment by hepatitis CIRES RNA. RNA. 2001;7:194–206. PubMed PMC

Terenin IM, Dmitriev SE, Andreev DE, Shatsky IN. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat Struct Mol Biol. 2008;15:836–841. PubMed

Pestova TV, de Breyne S, Pisarev AV, Abaeva IS, Hellen CU. eIF2-dependent and eIF2-independent modes of initiation on the CSFVIRES: a common role of domain II. Embo J. 2008;27:1060–1072. PubMed PMC

Honda M, Beard MR, Ping LH, Lemon SM. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol. 1999;73:1165–1174. PubMed PMC

Dibrov SM, Johnston-Cox H, Weng YH, Hermann T. Functional architecture of HCVIRES domain II stabilized by divalent metal ions in the crystal and in solution. Angew Chem Int Ed. 2007;46:226–229. PubMed

Zhao Q, Han Q, Kissinger CR, Hermann T, Thompson PA. Structure of hepatitis C virus IRES subdomain IIa. Acta Crystallogr Sect D Biol Crystallogr. 2008;64:436–443. PubMed

Tang SX, Collier AJ, Elliott RM. Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus ib 5′ untranslated region (5′ UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5′ UTR sequence. J Virol. 1999;73:2359–2364. PubMed PMC

Laporte J, Malet I, Andrieu T, Thibault V, Toulme JJ, Wychowski C, Pawlotsky JM, Huraux JM, Agut H, Cahour A. Comparative analysis of translation efficiencies of hepatitis C virus 5′ untranslated regions among intraindividual quasispecies present in chronic infection: Opposite behaviors depending on cell type. J Virol. 2000;74:10827–10833. PubMed PMC

Barria MI, Gonzalez A, Vera-Otarola J, Leon U, Vollrath V, Marsac D, Monasterio O, Perez-Acle T, Soza A, Lopez-Lastra M. Analysis of natural variants of the hepatitis C virus internal ribosome entry site reveals that primary sequence plays a key role in cap-independent translation. Nucleic Acids Res. 2009;37:957–971. PubMed PMC

Klinck R, Westhof E, Walker S, Afshar M, Collier A, Aboul-Ela F. A potential RNA drug target in the hepatitis C virus internal ribosomal entry site. RNA. 2000;6:1423–1431. PubMed PMC

Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ. SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. J Med Chem. 2005;48:7099–7102. et al. PubMed

Parsons J, Castaldi MP, Dutta S, Dibrov SM, Wyles DL, Hermann T. Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nat Chem Biol. 2009;5:823–825. PubMed PMC

Paulsen RB, Seth PP, Swayze EE, Griffey RH, Skalicky JJ, Cheatham TE, Davis DR. Inhibitor-induced structural change in the HCV IRES domain IIa RNA. Proc Natl Acad Sci USA. 2010;107:7263–7268. PubMed PMC

Dibrov SM, Ding K, Brunn ND, Parker MA, Bergdahl BM, Wyles DL, Hermann T. Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches. Proc Natl Acad Sci USA. 2012;109:5223–5228. PubMed PMC

Babaylova E, Graifer D, Malygin A, Stahl J, Shatsky I, Karpova G. Positioning of subdomain IIId and apical loop of domain II of the hepatitis C IRES on the human 40S ribosome. Nucleic Acids Res. 2009;37:1141–1151. PubMed PMC

Laletina E, Graifer D, Malygin A, Ivanov A, Shatsky I, Karpova G. Proteins surrounding hairpin IIIe of the hepatitis C virus internal ribosome entry site on the human 40S ribosomal subunit. Nucleic Acids Res. 2006;34:2027–2036. PubMed PMC

Fukushi S, Okada M, Stahl J, Kageyama T, Hoshino FB, Katayama K. Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus. J Biol Chem. 2001;276:20824–20826. PubMed

Boehringer D, Thermann R, Ostareck-Lederer A, Lewis JD, Stark H. Structure of the hepatitis C virus IRES bound to the human 80S ribosome: remodeling of the HCVIRES. Structure. 2005;13:1695–1706. PubMed

Filbin ME, Kieft JS. HCV IRES domain IIb affects the configuration of coding RNA in the 40S subunit′s decoding groove. RNA. 2011;17:1258–1273. PubMed PMC

Filbin ME, Vollmar BS, Shi D, Gonen T, Kieft JS. HCV IRES manipulates the ribosome to promote the switch from translation initiation to elongation. Nat Struct Mol Biol. 2013;20:150–158. PubMed PMC

Otto GA, Puglisi JD. The pathway of HCVIRES-mediated translation initiation. Cell. 2004;119:369–380. PubMed

Algire MA, Maag D, Lorsch JR. P-i release from elF2, not GTP hydrolysis, is the step controlled by start-site selection during eukaryotic translation initiation. Mol Cell. 2005;20:251–262. PubMed

Lee JH, Pestova TV, Shin BS, Cao C, Choi SK, Dever TE. Initiation factor eIF5B catalyzes second GTP-dependent step in eukaryotic translation initiation. Proc Natl Acad Sci USA. 2002;99:16689–16694. PubMed PMC

Jubin R, Vantuno NE, Kieft JS, Murray MG, Doudna JA, Lau JYN, Baroudy BM. Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol. 2000;74:10430–10437. PubMed PMC

Buratti E, Tisminetzky S, Zotti M, Baralle FE. Functional analysis of the interaction between HCV 5′ UTR and putative subunits of eukaryotic translation initiation factor elF3. Nucleic Acids Res. 1998;26:3179–3187. PubMed PMC

Wang CY, Sarnow P, Siddiqui A. A conserved helical element is essential for internal initiation of translation of hepatitis-C virus-Rna. J Virol. 1994;68:7301–7307. PubMed PMC

Buratti E, Gerotto M, Pontisso P, Alberti A, Tisminetzky SG, Baralle FE. In vivo translational efficiency of different hepatitis C virus 5′-UTRs. Febs Lett. 1997;411:275–280. PubMed

Zhang J, Yamada O, Ito T, Akiyama M, Hashimoto Y, Yoshida H, Makino R, Masago A, Uemura H, Araki H. A single nucleotide insertion in the 5′-untranslated region of hepatitis C virus leads to enhanced cap-independent translation. Virology. 1999;261:263–270. PubMed

Melcher SE, Wilson TJ, Lilley DMJ. The dynamic nature of the four-way junction of the hepatitis C virus IRES. RNA. 2003;9:809–820. PubMed PMC

Malygin AA, Kossinova OA, Shatsky IN, Karpova GG. HCV IRES interacts with the 18S rRNA to activate the 40S ribosome for subsequent steps of translation initiation. Nucleic Acids Res. 2013;41:8706–8714. PubMed PMC

Easton LE, Locker N, Lukavsky PJ. Conserved functional domains and a novel tertiary interaction near the pseudoknot drive translational activity of hepatitis C virus and hepatitis C virus-like internal ribosome entry sites. Nucleic Acids Res. 2009;37:5537–5549. PubMed PMC

Psaridi L, Georgopoulou U, Varaklioti A, Mavromara P. Mutational analysis of a conserved tetraloop in the 5′ untranslated region of hepatitis C virus identifies a novel RNA element essential for the internal ribosome entry site function. Febs Lett. 1999;453:49–53. PubMed

Wang CY, Le SY, Ali N, Siddiqui A. An Rna pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis-C virus 5′-noncoding region. RNA. 1995;1:526–537. PubMed PMC

Lavender CA, Ding F, Dokholyan NV, Weeks KM. Robust and generic RNA modeling using inferred constraints: a structure for the hepatitis C virus IRES pseudoknot domain. Biochemistry. 2010;49:4931–4933. PubMed PMC

Perard J, Leyrat C, Baudin F, Drouet E, Jamin M. Structure of the full-length HCV IRES in solution. Nat Commun. 2013;4:1612. PubMed

Rijnbrand RCA, Abbink TEM, Haasnoot PCJ, Spaan WJM, Bredenbeek PJ. The influence of AUG codons in the hepatitis C virus 5′ nontranslated region on translation and mapping of the translation initiation window. Virology. 1996;226:47–56. PubMed

Reynolds JE, Kaminski A, Carroll AR, Clarke BE, Rowlands DJ, Jackson RJ. Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA. 1996;2:867–878. PubMed PMC

Masek T, Vopalensky V, Horvath O, Vortelova L, Feketova Z, Pospisek M. Hepatitis C virus internal ribosome entry site initiates protein synthesis at the authentic initiation codon in yeast. J Gen Virol. 2007;88:1992–2002. PubMed

Reynolds JE, Kaminski A, Kettinen HJ, Grace K, Clarke BE, Carroll AR, Rowlands DJ, Jackson RJ. Unique features of internal initiation of hepatitis-C virus-Rna translation. Embo J. 1995;14:6010–6020. PubMed PMC

Rijnbrand R, Bredenbeek PJ, Haasnoot PC, Keift JS, Spaan WJM, Lemon SM. The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA. 2001;7:585–597. PubMed PMC

Vassilaki N, Friebe P, Meuleman P, Kallis S, Kaul A, Paranhos-Baccala G, Leroux-Roels G, Mavromara P, Bartenschlager R. Role of the hepatitis C virus core + 1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol. 2008;82:11503–11515. PubMed PMC

Kim YK, Lee SH, Kim CS, Seol SK, Jang SK. Long-range RNA-RNA interaction between the 5′ nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation. RNA. 2003;9:599–606. PubMed PMC

Wang TH, Rijnbrand RCA, Lemon SM. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis c virus. J Virol. 2000;74:11347–11358. PubMed PMC

Henke JI, Goergen D, Zheng JF, Song YT, Schuttler CG, Fehr C, Junemann C, Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. Embo J. 2008;27:3300–3310. PubMed PMC

Goergen D, Niepmann M. Stimulation of Hepatitis C Virus RNA translation by microRNA-122 occurs under different conditions in vivo and in vitro. Virus Res. 2012;167:343–352. PubMed

Diaz-Toledano R, Ariza-Mateos A, Birk A, Martinez-Garcia B, Gomez J. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5′ region of hepatitis C virus RNA. Nucleic Acids Res. 2009;37:5498–5510. PubMed PMC

Damoc E, Fraser CS, Zhou M, Videler H, Mayeur GL, Hershey JWB, Doudna JA, Robinson CV, Leary JA. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics. 2007;6:1135–1146. PubMed

Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E. Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science. 2005;310:1513–1515. PubMed

Cai Q, Todorovic A, Andaya A, Gao JY, Leary JA, Cate JHD. Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit. J Mol Biol. 2010;403:185–196. PubMed PMC

Zhou M, Sandercock AM, Fraser CS, Ridlova G, Stephens E, Schenauer MR, Yokoi-Fong T, Barsky D, Leary JA, Hershey JW. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc Natl Acad Sci USA. 2008;105:18139–18144. et al. PubMed PMC

Perard J, Rasia R, Medenbach J, Ayala I, Boisbouvier J, Drouet E, Baudin F. Human initiation factor eIF3 subunit b interacts with HCV IRES RNA through its N-terminal RNA recognition motif. Febs Lett. 2009;583:70–74. PubMed

Fraser CS, Hershey JWB, Doudna JA. The pathway of hepatitis C virus mRNA recruitment to the human ribosome. Nat Struct Mol Biol. 2009;16:397–404. PubMed PMC

Hashem Y, des Georges A, Dhote V, Langlois R, Liao HY, Grassucci RA, Pestova TV, Hellen CUT, Frank J. Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit. Nature. 2013;503:539–543. PubMed PMC

Sun C, Querol-Audi J, Mortimer SA, Arias-Palomo E, Doudna JA, Nogales E, Cate JH. Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation. Nucleic Acids Res. 41:7512–7521. PubMed PMC

Garaigorta U, Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe. 2013;6:513–522. 2009. PubMed PMC

Shimoike T, McKenna SA, Lindhout DA, Puglisi JD. Translational insensitivity to potent activation of PKR by HCV IRES RNA. Antiviral Res. 2009;83:228–237. PubMed

Toroney R, Nallagatla SR, Boyer JA, Cameron CE, Bevilacqua PC. Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A. J Mol Biol. 2010;400:393–412. PubMed PMC

Pestova TV, Lomakin IB, Lee JH, Choi SK, Dever TE, Hellen CUT. The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature. 2000;403:332–335. PubMed

Unbehaun A, Borukhov SI, Hellen CUT, Pestova TV. Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. Genes Dev. 2004;18:3078–3093. PubMed PMC

Roll-Mecak A, Cao C, Dever TE, Burley SK. X-ray structures of the universal translation initiation factor IF2/elF5B: conformational changes on GDP and GTP binding. Cell. 2000;103:781–792. PubMed

Kim JH, Park SM, Park JH, Keum SJ, Jang SK. eIF2A mediates translation of hepatitis C viral mRNA under stress conditions. Embo J. 2011;30:2454–2464. PubMed PMC

Dmitriev SE, Terenin IM, Andreev DE, Ivanov PA, Dunaevsky JE, Merrick WC, Shatsky IN. GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J Biol Chem. 2010;285:26779–26787. PubMed PMC

Robert F, Kapp LD, Khan SN, Acker MG, Kolitz S, Kazemi S, Kaufman RJ, Merrick WC, Koromilas AE, Lorsch JR. Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2 center dot GTP center dot Met-tRNA(i)(Met) ternary complex availability. Mol Biol Cell. 2006;17:4632–4644.  , et al. PubMed PMC

Lancaster AM, Jan E, Sarnow P. Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry site. RNA. 2006;12:894–902. PubMed PMC

Characterization of Hepatitis C Virus IRES Quasispecies - From the Individual to the Pool

HCVIVdb: The hepatitis-C IRES variation database